Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: a subgroup analysis of the randomised clinical TITAN study Article

publication date

  • January 1, 2024

webpage

published in

keywords

  • high-volume
  • low-volume
  • metachronous
  • metastatic castration-sensitive prostate cancer
  • oligometastatic
  • polymetastatic
  • synchronous

start page

  • 79

end page

  • 93

volume

  • 20

issue

  • 1